AtriCure's Q4 sales rise, losses narrow

February 22, 2010 by MedCity News

AtriCure Inc. posts higher sales and lower losses during the fourth quarter.

By Mary Vanac

MedCity News logo

WEST CHESTER, Ohio — Despite several challenges in 2009 — like a Dept. of Justice investigation and related whistleblower lawsuit — AtriCure Inc. (NSDQ:ATRC) advanced toward profitability, added regulator approvals for its cardiac surgical ablation systems and developed new avenues of growth.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.